QOQ Q4 FY 23 vs. Q4 FY 22: The Financials have been prepared in accordance with Ind AS (‘Indian Accounting Standards’): The Revenue from Operations is Rs. 3.40 Cr. in Q4 FY 23 as against Rs. 2.61 Cr. in Q4 FY 22,which is an increase of
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
82.8% women struggle to focus on work due to menstrual periods or pain associated with it India’s leading feminine hygiene brand, Everteen, has released findings of its 8th Annual Everteen Menstrual Hygiene Survey 2023. Everteen is one of the partners for #MHDay2023, which is also supported
* A new chapter in commitment to healthcare excellence * Special training to team for world-class treatment * CMD of KIMS hospitals Dr. B.Bhaskar Rao KIMS Hospital has taken another step forward in providing specialty services to patients. A specialty clinic exclusively for inflammatory bowel disease (IBD) was
India Pharma & India Medical Device 2023 aims to position India as a leading international healthcare hub and attract investments. The Union Minister of Health & Family Welfare and Chemicals & Fertilizers, Dr Mansukh Mandaviya today said, “There is a need to harness India's vast potential in the
FY23 revenue from operations up 16% YoY to Rs. 11,933 Crs FY23 EBITDA at Rs. 1,565 Crs. and PAT (Post NCI) at 425 Crs. Q4 FY23 revenue from operations up 20% YoY to Rs. 3,262 Crs Q4 FY23 EBITDA at Rs. 506 Crs. and PAT (Post NCI) at
Global pharma major Lupin Limited (Lupin) announced today the launch of its Satellite Laboratory in Vijayawada, Andhra Pradesh. The move is part of Lupin Diagnostics’ ongoing expansion aimed at enhancing access to high-quality testing services and increasing the diagnostics network across the country. The newly
Evercare Group (“the Group”), and Indus Health Plus today announced a new 12month exclusive partnership to provide extended care to beneficiaries of Indus Health Plus at Evercare facilities. Evercare, a healthcare service provider with facilities in India, Bangladesh, Pakistan, Kenya, and Nigeria, and Indus Health Plus,
For testing the FeNO levels of patients to help more & more patients know if they are suffering from Asthm Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients Used for simple clinical
Numen Health, India's largest Digital-First Heart Care platform today announced a partnership with Aster Hospitals to provide preventive and rehabilitative medical attention to patients from the comfort of their homes. As part of this collaboration, Numen Health platform will aid Aster Hospitals' cardiologists in remotely
